Desq Long
Sign in

Company

Lexeo Therapeutics, Inc.

LXEO · CIK 0001907108

SEC FORM 4
$16,561.76

Lexeo Therapeutics, Inc. (LXEO)

Sale of 3,345 shares at $4.9512 per share.

Reporting Person Townsend Richard Nolan · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001995218-26-000015 · filed 2026-08-19 · View filing →

SEC FORM 4
$6,464.06

Lexeo Therapeutics, Inc. (LXEO)

Sale of 1,304 shares at $4.9571 per share.

Reporting Person Otero Jose Manuel · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0002024096-26-000013 · filed 2026-08-19 · View filing →

SEC FORM 4
$20,202.53

Lexeo Therapeutics, Inc. (LXEO)

Sale of 4,117 shares at $4.9071 per share.

Reporting Person Tamayo Louis Edward · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0002083206-26-000007 · filed 2026-08-19 · View filing →